AGs Cut $102M Deal With Indivior In Suboxone Antitrust Case
More than three dozen state-level enforcers reached a $102.5 million deal on Friday with Indivior Inc. to resolve claims that the drugmaker monopolized the market for the opioid addiction treatment Suboxone...To view the full article, register now.
Already a subscriber? Click here to view full article